Aadi Bioscience, Inc. (AADI) Reports In-Line Q3 EPS

Aadi Bioscience, Inc. (NASDAQ: AADI) reported Q3 EPS of ($0.46), in-line with the analyst estimate of ($0.46). Revenue for the quarter came in at $7.21 million versus the consensus estimate of $6.59 million.

For earnings history and earnings-related data on Aadi Bioscience, Inc. (AADI) click here.

You May Also Be Interested In

• Winnebago Industries (WGO) Misses Q3 EPS by 11c ; Offers Guidance
• JPMorgan Upgrades PT Perusahaan Gas Negara Tbk (PGAS:JK) (PPAAF) to Overweight
• William Blair Downgrades Bio-Techne Corp. (TECH) to Market Perform